HEALY JAMES Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
10
Insider Buys Sum
$76.37M
Insider Sells Quantity
14
Insider Sells Sum
$152.38M

Insider Activity of HEALY JAMES

According to the SEC Form 4 filings, HEALY JAMES, being in a position of

  1. director at Rapport Therapeutics, Inc. Common Stock,
    оver the last 12 months, has bought 969480 shares for $20.36M, and sold 0 shares,
    over all time since 2026-10-28, has bought 969480 shares for $20.36M, and sold 0 shares.

Biography of HEALY JAMES

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $20,359,0801100
Sells
 $000

Comparison of Insiders on Amount of Buys and Sells

2026-10-28PurchaseRapport Therapeutics, Inc. Common Stock
RAPP
director
969,480
1.886%
$21.00$20.36M+11.51%
2024-01-30PurchaseArriVent BioPharma, Inc. Common Stock
AVBP
director
444,444
1.0049%
$18.00$8M0%
2023-12-13SaleNatera, Inc.
NTRA
director
644,000
0.727%
$58.75$37.84M+78.7%
2022-11-16SaleNatera, Inc.
NTRA
director
2,400
0.0025%
$37.71$90,498+32.18%
2021-09-29SaleCoherus BioSciences, Inc.
CHRS
director
286,076
0.3546%
$16.12$4.61M-26.09%
2021-09-28SaleCoherus BioSciences, Inc.
CHRS
director
48,329
0.0622%
$17.17$829,809-27.59%
2021-09-27SaleCoherus BioSciences, Inc.
CHRS
director
100,150
0.1287%
$18.06$1.81M-30.86%
2021-07-22PurchaseNatera, Inc.
NTRA
director
2,400
0.0025%
$113.00$271,200-39.35%
2021-02-09PurchaseBolt Biotherapeutics, Inc.
BOLT
director
450,000
36.7082%
$20.00$9M-58.82%
2019-07-02SaleCoherus BioSciences, Inc.
CHRS
director
320,000
0.451%
$22.61$7.24M-19.69%
2019-06-28SaleCoherus BioSciences, Inc.
CHRS
director
400,000
0.5744%
$22.05$8.82M-16.33%
2019-06-20SaleCoherus BioSciences, Inc.
CHRS
director
634,260
0.9007%
$21.37$13.55M-14.29%
2019-05-22SaleCoherus BioSciences, Inc.
CHRS
director
515,740
0.747%
$20.69$10.67M-9.48%
2018-08-29SaleCoherus BioSciences, Inc.
CHRS
director
50,000
0.075%
$20.50$1.02M-26.35%
2016-03-11PurchasePDS Biotechnology Corporation
PDSB
director
541,343
1.8335%
$7.30$3.95M+31.28%
2015-10-06PurchasePDS Biotechnology Corporation
PDSB
director
900,000
2.0157%
$11.00$9.9M-45.67%
2015-07-08PurchaseNatera, Inc.
NTRA
director
175,000
0.3264%
$18.00$3.15M-52.68%
2015-07-02PurchaseNatera, Inc.
NTRA
director
200,000
0.4464%
$22.81$4.56M-43.64%
2014-11-12PurchaseCoherus BioSciences, Inc.
CHRS
director
851,852
9.7417%
$13.50$11.5M+82.59%
2012-04-03SaleAmarin Corporation plc
AMRN
director
3.47M
2.4281%
$10.98$38.12M+1.07%
Total: 23
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.